Effects of macrophage-and granulocyte-colony stimulating factors on thymidylate synthase and thymidine kinase activity in rat hematopoietic cells

Haematologica

Volumn 82, Issue 2, 1997, Pages 187-188

  Kudo, Hideki ^a   Suzuki, Satoe ^b   Kuwa, Katsuhiko ^b   Nakayama, Tohru ^b   Maemura, Masatoshi ^b   Sakamoto, Shinobu ^b  

^a TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

G CSF; M CSF; Rat bone marrow cells; Thymidine kinase

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; THYMIDINE KINASE;

ACUTE LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEOTIDE METABOLISM; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BONE MARROW; CELLS, CULTURED; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE KINASE; THYMIDYLATE SYNTHASE;

EID: 0031451610     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dunlap RB, Harding NGL, Huennekens FM. Thymidylate synthase from amethopterin-resistant Lactobacillus casei. Biochemistry 1971; 10:88-97.
2. Taylor AT, Stafford MA, Jones OW. Properties of thymidine kinase partially purified from human fetal and adult tissue. J Biol Chem 1972; 247:1930-5.
3. Sakamoto S, Kuwa K, Tsukada T, Sagara T, Kasahara N, Okamoto R. Relative activities of thymidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine induced colon carcinomas in rats. Carcinogenesis 1987; 8:405-8.
4. Kudo H, Sakamoto S, Suzuki S, et al. Regulation of pyrimidine nucleotide synthesis in rat hematopoiesis. In Vivo 1994; 8:303-8.
5. Motoyoshi K, Yoshida K, Hatake K, et al. Recombinant and native human urinary colony-stimulating factor directly augments GM- and G-CSF production of human peripheral blood monocytes. Exp Hematol 1989; 17:68-71.
6. Brandt S, Peters WP, Atwater SK, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318:869-76.
7. Sheridan WP, Morstyn G, Wolf M, et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2:891-5.
8. Tafuri A, Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990; 4:826-34.
9. Lista P, Porcu P, Carlo G, Pegoraro L. Interleukin 3 enhances the cytotoxic activity of 1-β-D-arabinofuranosyl-cytosine (ara-C) on acute myeloblastic leukemia (AML) cells. Br J Haematol 1988; 69:121-3.
10. Kitano K, Kobayashi H, Maeyama H, Miyabayashi H, Furuta S. Treatment of acute monoblastic leukemia by combination of recombinant human macrophge colony-stimulating factor and low doses of ara-C. Br J Haematol 1993; 85:176-8.